# Recurrent Remitting Seronegative Symmetrical Synovitis With Pitting Edema in a Nonagenarian: An Atypical Clinical Course Requiring Methotrexate for Remission

**Authors:** Ken Sato

PMC · DOI: 10.1002/jgf2.70098 · Journal of General and Family Medicine · 2026-01-07

## TL;DR

A 92-year-old man with a rare arthritis condition called RS3PE did not fully respond to steroids but achieved remission with methotrexate.

## Contribution

This case report demonstrates that methotrexate can be effective in RS3PE when steroids are insufficient.

## Key findings

- The patient showed incomplete response to corticosteroids and relapsed despite dose escalation.
- Addition of methotrexate led to complete remission and normalization of inflammatory markers.

## Abstract

Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is a rare inflammatory arthritis of older adults. We report a 92‐year‐old man who presented with fatigue and distal pitting edema, fulfilling the clinical features of RS3PE. Although corticosteroids are typically effective, he showed an incomplete response and relapsed despite dose escalation. Addition of methotrexate resulted in complete remission, with normalization of inflammatory markers. Elderly‐onset rheumatoid arthritis and paraneoplastic RS3PE were considered but were clinically unlikely. This case highlights that RS3PE can occur even in nonagenarians and may require disease‐modifying therapy when corticosteroid responsiveness is insufficient.

## Linked entities

- **Chemicals:** methotrexate (PubChem CID 4112)
- **Diseases:** rheumatoid arthritis (MONDO:0008383)

## Full-text entities

- **Diseases:** Seronegative Symmetrical Synovitis (MESH:D013585), inflammatory arthritis (MESH:D001168), rheumatoid arthritis (MESH:D001172), Pitting Edema (MESH:D004487), inflammatory (MESH:D007249), paraneoplastic (MESH:D010257), fatigue (MESH:D005221)
- **Chemicals:** Methotrexate (MESH:D008727)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12897554/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12897554/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12897554/full.md

---
Source: https://tomesphere.com/paper/PMC12897554